A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
Clinical trial NCT06006559 · RECRUITING
Trial details
- NCT number
- NCT06006559
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-20
- Primary completion
- 2027-07-22
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.